IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Defilade Capital Management, L.P.

Q4 2025 Holdings

Filed 2026-02-13 | 33 holdings | $737.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pfizer Inc(PFE)COM717081103$54.9M2,203,5047.4%
Abbvie Inc(ABBV)COM00287Y109$52.0M227,6697.1%
Novartis AG(NVSN)SPONSORED ADR66987V109$50.0M362,8166.8%
ICU MED Inc(ICUI)COM44930G107$48.6M340,7456.6%
Pacs Group Inc(PACS)COM SHS69380Q107$44.0M1,145,4856.0%
ELI Lilly & Co(LLY)COM532457108$34.3M31,9504.7%
Steris PLC(STE)SHS USDG8473T100$34.3M135,3074.6%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$30.9M1,234,6344.2%
Revolution Medicines Inc(RVMD)COM76155X100$28.9M363,4543.9%
Biogen Inc(BIIB)COM09062X103$28.5M161,9923.9%
Nuvalent Inc(NUVL)COM670703107$27.1M269,0433.7%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$25.9M45,6623.5%
Henry Schein Inc(HSIC)COM806407102$24.2M320,4223.3%
Globus MED Inc(GMED)CL A379577208$23.3M267,2123.2%
Xencor Inc(XNCR)COM98401F105$21.7M1,414,7552.9%
Cogent Biosciences Inc(COGT)COM19240Q201$20.2M568,6192.7%
Align Technology Inc(ALGN)COM016255101$20.0M128,0602.7%
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$18.3M85,6942.5%
Dexcom Inc(DXCM)COM252131107$16.3M244,8812.2%
Becton Dickinson & Co(BDX)COM075887109$15.8M81,2072.1%
Atricure Inc(ATRC)COM04963C209$15.7M397,6362.1%
Livanova PLC(LIVN)SHSG5509L101$14.9M241,4132.0%
Alphatec Hldgs Inc(ATEC)COM NEW02081G201$13.2M626,7541.8%
Denali Therapeutics Inc(DNLI)COM24823R105$10.8M656,7131.5%
Glaukos Corp(GKOS)COM377322102$10.4M91,7031.4%
Rxsight Inc(RXST)COM78349D107$9.5M913,0901.3%
Elanco Animal Health Inc(ELAN)COM28414H103$9.1M401,2831.2%
Insmed Inc(INSM)COM PAR $.01457669307$8.7M50,0001.2%
Ocular Therapeutix Inc(OCUL)COM67576A100$8.3M681,6631.1%
Teleflex Incorporated(TFX)COM879369106$5.2M42,8500.7%
Eledon Pharmaceuticals Inc(ELDN)COM28617K101$5.0M3,290,4500.7%
Conmed Corp(CNMD)COM207410101$4.2M104,1290.6%
Evommune Inc(EVMN)COM SHS30054Y107$3.7M215,4180.5%